Compare Unichem Lab with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs DISHMAN PHARMA - Comparison Results

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB DISHMAN PHARMA UNICHEM LAB/
DISHMAN PHARMA
 
P/E (TTM) x 61.1 25.1 243.4% View Chart
P/BV x 0.7 3.3 19.6% View Chart
Dividend Yield % 2.1 0.7 317.6%  

Financials

 UNICHEM LAB   DISHMAN PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
DISHMAN PHARMA
Mar-16
UNICHEM LAB/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs292374 78.0%   
Low Rs182129 141.2%   
Sales per share (Unadj.) Rs167.7197.8 84.8%  
Earnings per share (Unadj.) Rs-3.621.2 -17.1%  
Cash flow per share (Unadj.) Rs5.934.7 17.1%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %1.70.8 212.4%  
Book value per share (Unadj.) Rs372.3179.9 206.9%  
Shares outstanding (eoy) m70.3880.69 87.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.41.3 111.1%   
Avg P/E ratio x-65.311.9 -550.1%  
P/CF ratio (eoy) x39.97.2 550.4%  
Price / Book Value ratio x0.61.4 45.5%  
Dividend payout %-110.29.4 -1,168.1%   
Avg Mkt Cap Rs m16,68020,306 82.1%   
No. of employees `0002.60.8 313.9%   
Total wages/salary Rs m2,3935,355 44.7%   
Avg. sales/employee Rs Th4,535.219,252.7 23.6%   
Avg. wages/employee Rs Th919.86,459.5 14.2%   
Avg. net profit/employee Rs Th-98.22,064.1 -4.8%   
INCOME DATA
Net Sales Rs m11,80115,961 73.9%  
Other income Rs m984265 370.8%   
Total revenues Rs m12,78516,226 78.8%   
Gross profit Rs m-8354,103 -20.3%  
Depreciation Rs m6741,091 61.8%   
Interest Rs m75944 8.0%   
Profit before tax Rs m-6002,334 -25.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m11 63.6%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343624 -55.1%   
Profit after tax Rs m-2561,711 -14.9%  
Gross profit margin %-7.125.7 -27.5%  
Effective tax rate %57.326.7 214.3%   
Net profit margin %-2.210.7 -20.2%  
BALANCE SHEET DATA
Current assets Rs m20,38411,018 185.0%   
Current liabilities Rs m5,0299,517 52.8%   
Net working cap to sales %130.19.4 1,383.7%  
Current ratio x4.11.2 350.1%  
Inventory Days Days105110 94.8%  
Debtors Days Days13535 387.2%  
Net fixed assets Rs m9,02316,304 55.3%   
Share capital Rs m141161 87.2%   
"Free" reserves Rs m26,05812,907 201.9%   
Net worth Rs m26,19914,516 180.5%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m31,49629,805 105.7%  
Interest coverage x-7.03.5 -200.9%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.40.5 70.0%   
Return on assets %-0.68.9 -6.4%  
Return on equity %-1.011.8 -8.3%  
Return on capital %-2.017.5 -11.4%  
Exports to sales %69.424.8 279.9%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs m8,1883,956 207.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m8,1884,952 165.4%   
Fx outflow Rs m596697 85.5%   
Net fx Rs m7,5924,255 178.4%   
CASH FLOW
From Operations Rs m-3,2782,786 -117.6%  
From Investments Rs m-2,860-1,529 187.1%  
From Financial Activity Rs m-24-941 2.6%  
Net Cashflow Rs m-4,690316 -1,482.4%  

Share Holding

Indian Promoters % 50.1 61.4 81.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 3.7 408.1%  
FIIs % 3.0 12.7 23.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 22.1 143.4%  
Shareholders   20,176 46,261 43.6%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   GSK PHARMA  JUBILANT LIFE SCIENCES  BIOCON   PIRAMAL ENTERPRISES  VENUS REMEDIES  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 642 Points; Automobile and Realty Stocks Plunge(Closing)

Indian share markets fell sharply today amid fears of rising crude oil prices and weakness in the rupee rattled investor sentiment.

Related Views on News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Sep 17, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS